Service d'angiologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


393 publications

Sous presse | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ...
 
Gait changes after supervised exercise training in patients with symptomatic lower extremity peripheral artery disease.
Lanzi S., Boichat J., Calanca L., Aubertin P., Malatesta D., Mazzolai L. Vascular medicine. Peer-reviewed.
 
Partial home confinement during the COVID-19 pandemic, physical function, and physical activity in patients with symptomatic lower extremity peripheral artery disease.
Lanzi S., Pousaz A., Buso G., Mazzolai L., Calanca L. Vascular medicine pp. 1358863X21995579. Peer-reviewed.
 
Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Sebastian T., Barco S., Banyai M., Beer J.H., Mazzolai L., Baldi T., Aujesky D., Hayoz D., Engelberger R.P. et al. Thrombosis and haemostasis. Peer-reviewed.
 
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.
Pappaccogli M., Di Monaco S., Warchoł-Celińska E., Lorthioir A., Amar L., Aparicio L.S., Beauloye C., Bruno R.M., Chenu P., de Leeuw P. et al., 2021/02/22. Cardiovascular research, 117 (3) pp. 950-959. Peer-reviewed.
 
Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation
Fernández-Capitán Carmen, Rodriguez Cobo Ana, Jiménez David, Madridano Olga, Ciammaichella Maurizio, Usandizaga Esther, Otero Remedios, Di Micco Pierpaolo, Moustafa Farès, Monreal Manuel et al., 2021/01. Research and Practice in Thrombosis and Haemostasis, 5 (1) pp. 168-178.
 
Clinical history of cancer‐associated splanchnic vein thrombosis
Valeriani Emanuele, Di Nisio Marcello, Riva Nicoletta, Caiano Lucia Maria, Porreca Ettore, Bang Soo Mee, Beyer-Westendorf Jan, Sartori Maria Teresa, Barillari Giovanni, Santoro Rita et al., 2020/12/11. Journal of Thrombosis and Haemostasis.
 
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
Zermatten M.G., Pantet O., Gomez F., Schneider A., Méan M., Mazzolai L., Hugli O., Bart P.A., Papadimitriou Olivgeris M., Alberio L. et al., 2020/12. Thrombosis research, 196 pp. 222-226. Peer-reviewed.
 
Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy.
Weissler E.H., Jones W.S., Desormais I., Debus S., Mazzolai L., Espinola-Klein C., Nikol S., Nehler M., Sillesen H., Aboyans V. et al., 2020/11/06. Atherosclerosis, 315 pp. 10-17. Peer-reviewed.
 
Syndrome de congestion pelvienne : une cause fréquente de douleur chronique [Pelvic congestion syndrome]
Ney B., Diserens C., Vial Y., Mazzolai L., 2020/10/28. Revue medicale suisse, 16 (712) pp. 2042-2045. Peer-reviewed.
 
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.
Mellado M., Trujillo-Santos J., Bikdeli B., Jiménez D., Núñez M.J., Ellis M., Marchena P.J., Vela J.R., Clara A., Moustafa F. et al., 2020/10. Internal and emergency medicine, 15 (7) p. 1357. Peer-reviewed.
 
Multimodal Supervised Exercise Significantly Improves Walking Performances Without Changing Hemodynamic Parameters in Patients With Symptomatic Lower Extremity Peripheral Artery Disease.
Calanca L., Lanzi S., Ney B., Berchtold A., Mazzolai L., 2020/10. Vascular and endovascular surgery, 54 (7) pp. 605-611. Peer-reviewed.
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S., Bingisser R., Colucci G., Frenk A., Gerber B., Held U., Mach F., Mazzolai L., Righini M., Rosemann T. et al., 2020/09/09. Trials, 21 (1) p. 770. Peer-reviewed.
Impact of aerobic exercise type on blood flow, muscle energy metabolism, and mitochondrial biogenesis in experimental lower extremity artery disease.
Pellegrin M., Bouzourène K., Aubert J.F., Bielmann C., Gruetter R., Rosenblatt-Velin N., Poitry-Yamate C., Mazzolai L., 2020/08/20. Scientific reports, 10 (1) p. 14048. Peer-reviewed.
 
Why optional inferior vena cava filters are not always retrieved? A real world 19 years experience in a Swiss tertiary care university hospital.
Buso G., Alatri A., Calanca L., Fresa M., Qanadli S.D., Pesavento R., Mazzolai L., 2020/06. European journal of internal medicine, 76 pp. 64-70. Peer-reviewed.
Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis.
Delluc A., Miranda S., Exter P.D., Louzada M., Alatri A., Ahn S., Monreal M., Khorana A., Huisman M.V., Wells P.S. et al., 2020/05. Haematologica, 105 (5) pp. 1436-1442. Peer-reviewed.
 
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I., Cote L., Iftikhar O., Brenner B., Tafur A., Bikdeli B., Fernández-Capitán C., Pedrajas J.M., Otero R., Quintavalla R. et al., 2020/05. Journal of vascular surgery. Venous and lymphatic disorders, 8 (3) pp. 353-359.e1. Peer-reviewed.
 
Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspect.
Tufano A., López-Jiménez L., Bikdeli B., García-Bragado F., Mazzolai L., Amitrano M., Gómez-Cuervo C., Marchena P.J., Madridano O., Monreal M. et al., 2020/04/15. International journal of cardiology, 305 pp. 115-119. Peer-reviewed.
 
Aspirine en prévention cardiovasculaire primaire : la fin d’une époque ? [Aspirin for primary cardiovascular prevention : the end of an era ?]
Ravach G., Fournier S., Mazzolai L., Nanchen D., 2020/03/04. Revue medicale suisse, 16 (684) pp. 459-462. Peer-reviewed.
 
Oxygen as a key regulator of cardiomyocyte proliferation: New results about cell culture conditions!
Bon-Mathier A.C., Rignault-Clerc S., Bielmann C., Rosenblatt-Velin N., 2020/03. Biochimica et biophysica acta. Molecular cell research, 1867 (3) p. 118460. Peer-reviewed.
 
ABI et risque cardiovasculaire
Calanca Luca, 2020/02. La Gazzette médicale, 9 (1).
 
The year in cardiology: aorta and peripheral circulation.
Heiss C., Pitcher A., Belch JJF, De Carlo M., Reinecke H., Baumgartner I., Mazzolai L., Aboyans V., 2020/01/21. European heart journal, 41 (4) pp. 501-508b. Peer-reviewed.
 
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
Avnery O., Martin M., Bura-Riviere A., Barillari G., Mazzolai L., Mahé I., Marchena P.J., Verhamme P., Monreal M., Ellis M.H. et al., 2020/01. Journal of internal medicine, 287 (1) pp. 32-41. Peer-reviewed.
Fat Oxidation Kinetics Is Related to Muscle Deoxygenation Kinetics During Exercise.
Zurbuchen A., Lanzi S., Voirol L., Trindade C.B., Gojanovic B., Kayser B., Bourdillon N., Chenevière X., Malatesta D., 2020. Frontiers in physiology, 11 p. 571. Peer-reviewed.
 
Physical Activity and Endurance Training Modalities: Evidences and Perspectives
Malatesta Davide, Fanari Paolo, Salvadori Alberto, Lanzi Stefano, 2020. pp. 1-18 dans Rehabilitation interventions in the patient with obesity, Springer International Publishing.
 
The Bleeding Risk in Antithrombotic Therapies: A Narrative Review.
Alatri A., Mazzolai L., 2020. Current vascular pharmacology, 18 (3) pp. 237-248. Peer-reviewed.
 
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years.
Jara-Palomares L., Alfonso M., Maestre A., Jimenez D., Garcia-Bragado F., Font C., Reyes R.L., Blasco L.H., Vidal G., Otero R. et al., 2019/12/27. Scientific reports, 9 (1) p. 20064. Peer-reviewed.
 
Artériopathie oblitérante des membres inférieurs : complications locales et systémiques [Lower extremity peripheral artery disease : local and systemic complications]
Calanca L., Alatri A., Lanzi S., Deglise S., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2247-2250. Peer-reviewed.
 
Artériopathie oblitérante des membres inférieurs : nouveautés dans la thérapie médicamenteuse [Patient with lower extremity artery disease : news in therapeutic approach]
Maufus M., Alatri A., Fresa M., Erdmann A., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2242-2246. Peer-reviewed.
 
Faut-il dépister l’artériopathie oblitérante des membres inférieurs chez les patients avec diabète de type [Should patients with type 2 diabetes be screened for lower extremity arterial disease?]
Buso G., Collet T.H., Wojtusciszyn A., Maufus M., Ney B., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2236-2240. Peer-reviewed.
 
Maladies vasculaires ­périphériques et prévention secondaire : un appel à agir
Mazzolai L., Fontana P., Righini M., 2019/12/04. Revue medicale suisse, 15 (674) p. 2227. Peer-reviewed.
 
Traitement par l’exercice physique chez le patient avec une artériopathie oblitérante des membres inférieurs [Exercise training therapy in patients with lower extremity peripheral artery disease]
Lanzi S., Ney B., Deslarzes-Dubuis C., Mazzolai L., Calanca L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2252-2255. Peer-reviewed.
 
Épaisseur intima-média et plaques carotido-fémorales pour stratifier le risque cardiovasculaire [Intima-media thickness and carotidofemoral plaques for cardiovascular risk stratification]
Erdmann A., Fresa M., Buso G., Ney B., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2229-2231. Peer-reviewed.
 
Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.
Venermo M., Sprynger M., Desormais I., Björck M., Brodmann M., Cohnert T., De Carlo M., Espinola-Klein C., Kownator S., Mazzolai L. et al., 2019/12. European journal of preventive cardiology, 26 (18) pp. 1971-1984. Peer-reviewed.
 
Lower extremity artery disease in patients with type 2 diabetes.
Buso G., Aboyans V., Mazzolai L., 2019/12. European journal of preventive cardiology, 26 (2_suppl) pp. 114-124. Peer-reviewed.
 
Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results.
Dotta-Celio J., Alatri A., Locatelli I., Salvi M., Bugnon O., Schneider M.P., Mazzolai L., 2019/12. International journal of clinical pharmacy, 41 (6) pp. 1625-1633. Peer-reviewed.
Towards Quantification of Inflammation in Atherosclerotic Plaque in the Clinic - Characterization and Optimization of Fluorine-19 MRI in Mice at 3 T.
Darçot E., Colotti R., Pellegrin M., Wilson A., Siegert S., Bouzourene K., Yerly J., Mazzolai L., Stuber M., van Heeswijk R.B., 2019/11/25. Scientific reports, 9 (1) p. 17488. Peer-reviewed.
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux A.J., Aubry D., Heulot M., Widmann C., ElMokh O., Piacente F., Cea M., Nencioni A., Bellotti A., Bouzourène K. et al., 2019/11/19. Oncotarget, 10 (62) pp. 6723-6738. Peer-reviewed.
EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond.
Bajc M., Schümichen C., Grüning T., Lindqvist A., Le Roux P.Y., Alatri A., Bauer R.W., Dilic M., Neilly B., Verberne H.J. et al., 2019/11. European journal of nuclear medicine and molecular imaging, 46 (12) pp. 2429-2451. Peer-reviewed.
 
Editor's Choice - Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.
Venermo M., Sprynger M., Desormais I., Björck M., Brodmann M., Cohnert T., De Carlo M., Espinola-Klein C., Kownator S., Mazzolai L. et al., 2019/11. European journal of vascular and endovascular surgery, 58 (5) pp. 641-653. Peer-reviewed.
 
The compelling arguments for the need of medical vascular physicians in Europe.
Heiss C., Madaric J., Belch J., Brodmann M., Mazzolai L., 2019/11. VASA. Zeitschrift fur Gefasskrankheiten, 48 (6) pp. 487-491. Peer-reviewed.
 
Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Sebastian T., Banyai M., Beer J.H., Mazzolai L., Baldi T., Aujesky D., Hayoz D., Engelberger R.P., Kaeslin T. et al., 2019/11. Seminars in thrombosis and hemostasis, 45 (8) pp. 851-858. Peer-reviewed.
 
Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry.
Bikdeli B., Jiménez D., Garcia-Tsao G., Barba R., Font C., Díaz-Pedroche MDC, Mazzolai L., Little DHW, Tufano A., Tafur A.J. et al., 2019/11. Seminars in thrombosis and hemostasis, 45 (8) pp. 793-801. Peer-reviewed.
Lipedema: A Call to Action!
Buso G., Depairon M., Tomson D., Raffoul W., Vettor R., Mazzolai L., 2019/10. Obesity, 27 (10) pp. 1567-1576. Peer-reviewed.
Prospective associations between maternal stress during pregnancy and fasting glucose with obstetric and neonatal outcomes.
Horsch A., Gilbert L., Lanzi S., Kang J.S., Vial Y., Puder J.J., 2019/10. Journal of psychosomatic research, 125 p. 109795. Peer-reviewed.
 
Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.
Mellado M., Trujillo-Santos J., Bikdeli B., Jiménez D., Núñez M.J., Ellis M., Marchena P.J., Vela J.R., Clara A., Moustafa F. et al., 2019/10. Internal and emergency medicine, 14 (7) pp. 1101-1112. Peer-reviewed.
 
Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry.
Murgier M., Bertoletti L., Darmon M., Zeni F., Valle R., Del Toro J., Llamas P., Mazzolai L., Villalobos A., Monreal M. et al., 2019/09/15. International journal of cardiology, 291 pp. 121-126. Peer-reviewed.
 
ESVM Guideline on peripheral arterial disease.
Frank U., Nikol S., Belch J., Boc V., Brodmann M., Carpentier P.H., Chraim A., Canning C., Dimakakos E., Gottsäter A. et al., 2019/09. VASA. Zeitschrift fur Gefasskrankheiten, 48 (Suppl 102) pp. 1-79. Peer-reviewed.
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V., Pisano M., Lessert C., Petit B., Bouzourene K., Nahimana A., Vozenin M.C., Stergiopulos N., Swartz M.A., Mazzolai L., 2019/06. European journal of vascular and endovascular surgery, 57 (6) pp. 859-867. Peer-reviewed.
 
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database.
Fuentes H.E., Tafur A.J., Caprini J.A., Alatri A., Trujillo-Santos J., Farge-Bancel D., Rosa V., Font L., Vilaseca A., Monreal M. et al., 2019/06. International angiology, 38 (3) pp. 173-184. Peer-reviewed.
 
Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular Medicine.
Constans J., Bura-Rivière A., Visona A., Brodmann M., Abraham P., Olinic D.M., Madaric J., Steiner S., Quéré I., Mazzolai L. et al., 2019/05. VASA. Zeitschrift fur Gefasskrankheiten, 48 (3) pp. 223-227. Peer-reviewed.
Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
Le Gal L., Pellegrin M., Santoro T., Mazzolai L., Kurtz A., Meda P., Wagner C., Haefliger J.A., 2019/04/16. Journal of the American Heart Association, 8 (8) pp. e010823. Peer-reviewed.
 
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.
Pastori D., Eikelboom J.W., Anand S.S., Patel M.R., Tanguay J.F., Ricco J.B., Debus E.S., Mazzolai L., Bauersachs R., Verhamme P. et al., 2019/04. Thrombosis and haemostasis, 119 (4) pp. 576-585. Peer-reviewed.
 
Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice.
Lavier J., Beaumann M., Ménetrey S., Mazzolai L., Peyter A.C., Pellegrin M., Millet G.P., 2019/03/15. Journal of visualized experiments 145. Peer-reviewed.
 
The year 2018 in cardiology: aorta and peripheral circulation.
Aboyans V., Vrsalovic M., Madaric J., Mazzolai L., De Carlo M., ESC Working Group on Aorta and Peripheral Vascular Diseases, 2019/03/14. European heart journal, 40 (11) pp. 872-879. Peer-reviewed.
 
ESVM integrated care pathways - a call for action.
Visonà A., Pesavento R., Mazzolai L., Cimminiello C., Pécsvárady Z., Olinic D., Johansson E., 2019/03. VASA. Zeitschrift fur Gefasskrankheiten, 48 (2) pp. 113-114. Peer-reviewed.
 
Accès vasculaire du patient hémodialysé - Que doit savoir le spécialiste en médecine interne générale ? [The vascular access of hemodialysis patients - What should the primary care physician know about ?]
Pivin E., Cunha Moreira Da Silva F.A., Calanca L., Deglise S., Pruijm M., 2019/02/20. Revue medicale suisse, 15 (639) pp. 439-443. Peer-reviewed.
How diet, physical activity and psychosocial well-being interact in women with gestational diabetes mellitus: an integrative review.
Gilbert L., Gross J., Lanzi S., Quansah D.Y., Puder J., Horsch A., 2019/02/07. BMC pregnancy and childbirth, 19 (1) p. 60. Peer-reviewed.
A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A., Calzavarini S., Limacher A., Mean M., Righini M., Staub D., Beer J.H., Frauchiger B., Osterwalder J., Kucher N. et al., 2019/02. Journal of thrombosis and haemostasis, 17 (2) pp. 306-318. Peer-reviewed.
 
Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry.
Mastroiacovo D., Dentali F., di Micco P., Maestre A., Jiménez D., Soler S., Sahuquillo J.C., Verhamme P., Fidalgo Á., López-Sáez J.B. et al., 2019/02. The European respiratory journal, 53 (2). Peer-reviewed.
 
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function.
Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R., Brekelmans MPA, Büller H.R., Elias A., Farge D. et al., 2018/12/14. European heart journal, 39 (47) pp. 4208-4218. Peer-reviewed.
 
Anticoagulation à faible dose : is less more ? []
Fontana P., Mazzolai L., Righini M., 2018/12/05. Revue medicale suisse, 14 (630) p. 2191. Peer-reviewed.
 
Traitement médical optimal de l’artériopathie oblitérante des membres inférieurs en 2018 [Best medical treatment of lower extremity arterial disease in 2018]
Buso G., Calanca L., Ney B., Fresa M., Mazzolai L., 2018/12/05. Revue medicale suisse, 14 (630) pp. 2202-2206. Peer-reviewed.
Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature.
Lanzi S., Calanca L., Borgeat Kaeser A., Mazzolai L., 2018/12. European heart journal. Case reports, 2 (4) pp. yty123. Peer-reviewed.
 
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry.
Weinberg I., Giri J., Kolluri R., Arcelus J.I., Falgá C., Soler S., Braester A., Bascuñana J., Gutiérrez-Guisado J., Monreal M. et al., 2018/11. Journal of thrombosis and thrombolysis, 46 (4) pp. 551-558. Peer-reviewed.
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M., Bouzourène K., Aubert J.F., Nahimana A., Duchosal M.A., Mazzolai L., 2018/09/04. International journal of molecular sciences, 19 (9) pp. E2621. Peer-reviewed.
 
Commentaries on Viewpoint: V̇o<sub>2peak</sub> is an acceptable estimate of cardiorespiratory fitness but not V̇o<sub>2max</sub>.
Zuo L., Zhou T., Malatesta D., Lanzi S., Millet G.P., Pogliaghi S., Paterson D.H., Murias J.M., van der Zwaard S., Jaspers R.T. et al., 2018/09/01. Journal of applied physiology, 125 (3) pp. 966-967. Peer-reviewed.
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
Senzolo M., Riva N., Dentali F., Rodriguez-Castro K., Sartori M.T., Bang S.M., Martinelli I., Schulman S., Alatri A., Beyer-Westendorf J. et al., 2018/08/15. Clinical and translational gastroenterology, 9 (8) p. 176. Peer-reviewed.
 
Commentaries on Viewpoint: Use aerobic energy expenditure instead of oxygen uptake to quantify exercise intensity and predict endurance performance.
Barnes K.R., Kilding A.E., Blagrove R.C., Howatson G., Hayes P.R., Boone J., Bourgois J., Fletcher J.R., MacIntosh B.R., González-Mohíno F. et al., 2018/08/01. Journal of applied physiology, 125 (2) pp. 676-682. Peer-reviewed.
 
Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis.
Méan M., Limacher A., Alatri A., Aujesky D., Mazzolai L., 2018/08. Thrombosis and haemostasis, 118 (8) pp. 1419-1427. Peer-reviewed.
 
Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
Blum M.R., Gencer B., Adam L., Feller M., Collet T.H., da Costa B.R., Moutzouri E., Dopheide J., Depairon M., Sykiotis G.P. et al., 2018/08/01. The Journal of clinical endocrinology and metabolism, 103 (8) pp. 2988-2997. Peer-reviewed.
 
Œdèmes des membres inférieurs: cas particuliers
Agapitou Eleni, Ney Barbara, Deslarzes-Dubuis Céline, Qanadli Salah Dine, Calanca Luca, 2018/07/10. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis.
Bikdeli B., Sharif-Kashani B., Bikdeli B., Valle R., Falga C., Riera-Mestre A., Mazzolai L., Verhamme P., Wells P.S., Torrero JFSM et al., 2018/06. Seminars in thrombosis and hemostasis, 44 (4) pp. 341-347. Peer-reviewed.
 
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
Lauber S., Limacher A., Tritschler T., Stalder O., Méan M., Righini M., Aschwanden M., Beer J.H., Frauchiger B., Osterwalder J. et al., 2018/06. The American journal of medicine, 131 (6) pp. 703.e7-703.e16. Peer-reviewed.
Chemical shift encoding (CSE) for sensitive fluorine-19 MRI of perfluorocarbons with complex spectra.
van Heeswijk R.B., Colotti R., Darçot E., Delacoste J., Pellegrin M., Piccini D., Hernando D., 2018/05. Magnetic resonance in medicine, 79 (5) pp. 2724-2730. Peer-reviewed.
 
Pathophysiology of telangiectasias of the lower legs and its therapeutic implication: A systematic review.
Kern P., 2018/05. Phlebology, 33 (4) pp. 225-233. Peer-reviewed.
 
Suitability for catheter-directed thrombolysis in patients with acute lower extremity deep vein thrombosis according to various international consensus guidelines.
Stefanescu A., Alatri A., Périard D., Kucher N., Mazzolai L., Engelberger R.P., 2018/05. Thrombosis research, 165 pp. 112-115. Peer-reviewed.
 
Thrombose veineuse profonde
Alatri Adriano, Ney Barbara, Fresa Marco, Erdmann Andreas, 2018/05/01. Info@herz+gefass.
 
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
Kuperman A., López-Reyes R., Bosco L.J., Lorenzo A., José B., Farge Bancel D., Alfonso M., Lumbierres M., Stemer G., Monreal Bosch M. et al., 2018/04. Journal of thrombosis and thrombolysis, 45 (3) pp. 360-368. Peer-reviewed.
 
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
Chai-Adisaksopha C., Iorio A., Crowther M.A., de Miguel J., Salgado E., Zdraveska M., Fernández-Capitán C., Nieto J.A., Barillari G., Bertoletti L. et al., 2018/04. The American journal of medicine, 131 (4) pp. 430-437. Peer-reviewed.
 
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V., Ricco J.B., Bartelink MEL, Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debus S. et al., 2018/03. European journal of vascular and endovascular surgery, 55 (3) pp. 305-368. Peer-reviewed.
 
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).
Aboyans V., Björck M., Brodmann M., Collet J.P., Czerny M., De Carlo M., Naylor A.R., Roffi M., Tendera M., Vlachopoulos C. et al., 2018/03/01. European heart journal, 39 (9) pp. e35-e41. Peer-reviewed.
 
The year 2017 in cardiology: aorta and peripheral circulation.
Aboyans V., Braekkan S., Mazzolai L., Sillesen H., Venermo M., De Carlo M., ESC Working Group on Aorta and Peripheral Vascular Diseases, 2018/03/01. European heart journal, 39 (9) pp. 730-738. Peer-reviewed.
Improving cardiometabolic and mental health in women with gestational diabetes mellitus and their offspring: study protocol for <i>MySweetHeart Trial</i>, a randomised controlled trial.
Horsch A., Gilbert L., Lanzi S., Gross J., Kayser B., Vial Y., Simeoni U., Hans D., Berney A., Scholz U. et al., 2018/02/27. BMJ open, 8 (2) pp. e020462. Peer-reviewed.
 
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V., Ricco J.B., Bartelink MEL, Bjorck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debusa S. et al., 2018/02. Revista espanola de cardiologia, 71 (2) p. 111. Peer-reviewed.
Angiotensinergic Innervation of the Human Right Atrium: Implications for Cardiac Reflexes.
Bohlender J.M., Nussberger J., Tevaearai H., Imboden H., 2018/01/12. American journal of hypertension, 31 (2) pp. 188-196. Peer-reviewed.
 
Exercise Training Modalities in Lower Limb Peripheral Artery Disease
Lanzi Stefano, Mazzolai Lucia, Calanca Luca, 2018. pp. 439-444 dans Practical Issues in Geriatrics, Springer International Publishing.
 
Il est temps d’agir! []
Mazzolai L., 2018. Praxis, 107 (20) p. 1069. Peer-reviewed.
 
Le lipœdème, cet inconnu [Lipedema, the Unknown]
Depairon M., Tomson D., Lessert C., Mazzolai L., 2018. Praxis, 107 (20) pp. 1071-1076. Peer-reviewed.
 
Le défi des maladies vasculaires rares : l’union fait la force ! []
Mazzolai L., Fontana P., Righini M., 2017/12/06. Revue medicale suisse, 13 (586) p. 2107. Peer-reviewed.
 
Lymphœdème primaire [Primary lymphedema]
Depairon M., Lessert C., Tomson D., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2124-2128. Peer-reviewed.
 
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV [Rare vascular diseases, building dedicated multidisciplinary specialized center]
Krieger C., Baud D., Bouchardy J., Christen-Zaech S., De Buys A., Deglise S., El Ezzi O., Fresa M., Hofer M., Hohl D. et al., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2109-2115. Peer-reviewed.
 
Thromboangéite oblitérante :notions pour la pratique [Thromboangiitis obliterans: notions for practice]
Calanca L., Alatri A., Krieger C., Corpataux J.M., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2129-2133. Peer-reviewed.
 
Thromboses veineuses profondes de localisation inhabituelle [Deep vein thrombosis in uncommon localisations]
Erdmann A., Ney B., Qanadli S.D., Calanca L., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2134-2137. Peer-reviewed.
 
Traitement des malformations veineuses chez l’adulte : rôle de la sclérothérapie échoguidée [The treatment of venous malformations in adult patients: the role of US-guided sclerotherapy]
Fresa M., Erdmann A., El Ezzi O., De Buys A., Depairon M., Dabiri A., Ney B., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2116-2120. Peer-reviewed.
 
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M., Angelillo-Scherrer A., Méan M., Limacher A., Abbal C., Righini M., Beer J.H., Osterwalder J., Frauchiger B., Aschwanden M. et al., 2017/11. Journal of thrombosis and haemostasis, 15 (11) pp. 2165-2175. Peer-reviewed.
 
The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry.
Alatri A., Mazzolai L., Kucher N., Aujesky D., Beer J.H., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2017/11. Seminars in thrombosis and hemostasis, 43 (8) pp. 871-876. Peer-reviewed.
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.
Moustafa F., Giorgi Pierfranceschi M., Di Micco P., Bucherini E., Lorenzo A., Villalobos A., Nieto J.A., Valero B., Sampériz Á.L., Monreal M. et al., 2017/10. Research and practice in thrombosis and haemostasis, 1 (2) pp. 172-179. Peer-reviewed.
 
Hypertension et dysplasie fibromusculaire :au-delà des artères rénales [Fibromuscular dysplasia and hypertension : beyond renal arteries]
Wuerzner G., Krieger C., Bouchardy J., Toubiana L., Delmotte P., Van der Niepen P., Déglise S., Qanadli S., Burnier M., Mazzolai L. et al., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1580-1583. Peer-reviewed.
 
Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
Engeli S., May M., Nussberger J., Danser AHJ, Dole W.P., Prescott M.F., Dahlke M., Stitah S., Pal P., Boschmann M. et al., 2017/08. Journal of the American Society of Hypertension, 11 (8) pp. 488-497. Peer-reviewed.
 
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A., Mazzolai L., Font C., Tafur A., Valle R., Marchena P.J., Ballaz A., Tiraferri E., Font L., Monreal M. et al., 2017/07/26. Thrombosis and haemostasis, 117 (8) pp. 1630-1636. Peer-reviewed.
 
Are ACE inhibitors acceptable ingredients in polypills?
Messerli F.H., Bangalore S., Rimoldi S.F., Gąsowski J., Nussberger J., 2017/07/01. Lancet, 390 (10089) p. 26. Peer-reviewed.
 
Tip malposition of peripherally inserted central catheters: a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement.
Glauser F., Breault S., Rigamonti F., Sotiriadis C., Jouannic A.M., Qanadli S.D., 2017/07. European radiology, 27 (7) pp. 2843-2849. Peer-reviewed.
 
Prévalence d’une sténose carotidienne chez le nonagénaire : résultats d’une enquête hospitalière [Prevalence of carotid artery stenosis in nonagenarians: Survey in a primary care hospital]
Bohlender J., Nussberger J., Ménard J., Bohlender B., 2017/06. Annales de cardiologie et d'angeiologie, 66 (3) pp. 130-134. Peer-reviewed.
 
Resetting of renal tissular renin-angiotensin and bradykinin-kallikrein systems after unilateral kidney denervation in rats.
Bohlender J.M., Nussberger J., Birkhäuser F., Grouzmann E., Thalmann G.N., Imboden H., 2017/05. Histochemistry and cell biology, 147 (5) pp. 585-593. Peer-reviewed.
 
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism.
Barrios D., Chavant J., Jiménez D., Bertoletti L., Rosa-Salazar V., Muriel A., Viallon A., Fernández-Capitán C., Yusen R.D., Monreal M. et al., 2017/05. The American journal of medicine, 130 (5) pp. 588-595. Peer-reviewed.
 
The year in cardiology 2016: peripheral circulation.
De Carlo M., Mazzolai L., Bossone E., Brodmann M., Micari A., Muiesan M.L., Ricco J.B., Stabile E., Agnelli G., Aboyans V. et al., 2017/04/07. European heart journal, 38 (14) pp. 1028-1033. Peer-reviewed.
 
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I., Papadakis M., Brenner B., Fidalgo Á., Rivas A., Wells P.S., Gavín O., Adarraga M.D., Moustafa F., Monreal M. et al., 2017/04. The American journal of medicine, 130 (4) pp. 482.e1-482.e9. Peer-reviewed.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz J.I., Lensing AWA, Prins M.H., Bauersachs R., Beyer-Westendorf J., Bounameaux H., Brighton T.A., Cohen A.T., Davidson B.L., Decousus H. et al., 2017/03/30. The New England journal of medicine, 376 (13) pp. 1211-1222. Peer-reviewed.
 
Prise en charge interventionnelle de l’insuffisance veineuse superficielle des membres inférieurs [Interventional treatment of venous insufficiency]
Ney B., Engelberger R.P., Dabiri A., Lüthi J.F., Erdmann A., Krieger C., Déglise S., Merminod T., Kern P., Mazzolai L., 2017/03/15. Revue medicale suisse, 13 (554) pp. 618-622. Peer-reviewed.
 
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.
Jara-Palomares L., Otero R., Jimenez D., Carrier M., Tzoran I., Brenner B., Margeli M., Praena-Fernandez J.M., Grandone E., Monreal M. et al., 2017/03. Chest, 151 (3) pp. 564-571. Peer-reviewed.
 
Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á., Trujillo-Santos J., Pesavento R., Rosa V., Falgá C., Tolosa C., Mazzolai L., Sampériz Á., Duce R., Monreal M. et al., 2017/03. Thrombosis research, 151 Suppl 1 pp. S6-S10. Peer-reviewed.
 
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.
Mahé I., Chidiac J., Bertoletti L., Font C., Trujillo-Santos J., Peris M., Pérez Ductor C., Nieto S., Grandone E., Monreal M. et al., 2017/03. The American journal of medicine, 130 (3) pp. 337-347. Peer-reviewed.
 
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.
Faller N., Limacher A., Méan M., Righini M., Aschwanden M., Beer J.H., Frauchiger B., Osterwalder J., Kucher N., Lämmle B. et al., 2017/02. The American journal of medicine, 130 (2) pp. 198-206. Peer-reviewed.
 
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
Trujillo-Santos J., Di Micco P., Dentali F., Douketis J., Díaz-Peromingo J.A., Núñez M.J., Cañas I., Mastroiacovo D., Saraiva de Sousa M., Monreal M. et al., 2017/01/26. Thrombosis and haemostasis, 117 (2) pp. 382-389. Peer-reviewed.
 
Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
Newton D.H., Monreal Bosch M., Amendola M., Wolfe L., Perez Ductor C., Lecumberri R., Levy M.M., RIETE Investigators, 2017/01. Journal of vascular surgery. Venous and lymphatic disorders, 5 (1) pp. 18-24.e1. Peer-reviewed.
 
Bradykinin in idiopathic non-histaminergic angioedema.
Cugno M., Tedeschi A., Nussberger J., 2017/01. Clinical and experimental allergy, 47 (1) pp. 139-140. Peer-reviewed.
 
Mastering Mitral Leaflets Coaptation After Valve Repair with Adjustable Mitral Annuloplasty Ring: Proof of Concept in Mock Loop Study.
Tozzi P., Hayoz D., Antona C., Fiore G.B., Siniscalchi G., Ferrari E., Baeriswyl G., Vismara R., 2017. ASAIO journal (American Society for Artificial Internal Organs : 1992), 63 (2) pp. 168-173. Peer-reviewed.
 
Intérêt de l’échographie de contraste aux microbulles en médecine vasculaire [Relevance of contrast ultrasound with microbubbles in vascular medecine]
Erdmann A., Ney B., Alatri A., Calanca L., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2131-2134. Peer-reviewed.
 
La maladie thrombo-embolique veineuse : une pathologie souvent oubliée
Righini M., Fontana P., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2099-2100. Peer-reviewed.
 
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M., Galanaud J.P., Guenneguez H., Brisot D., Diard A., Faisse P., Barrellier M.T., Hamel-Desnos C., Jurus C., Pichot O. et al., 2016/12. The Lancet. Haematology, 3 (12) pp. e556-e562. Peer-reviewed.
 
Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: "Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps". Ann Endocrinol 2016.
Douillard C., Houillier P., Nussberger J., Girerd X., 2016/12. Annales d'endocrinologie, 77 (6) p. 676. Peer-reviewed.
 
Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: "Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps". Ann Endocrinol 2016.
Douillard C., Houillier P., Nussberger J., Girerd X., 2016/12. Annales d'endocrinologie, 77 (6) p. 676. Peer-reviewed.
 
Pneumopathie toxique à la nitrofurantoïne
Tornay Joséphine , Lazor Romain , Uldry Christophe , Coronado Marcos , 2016/12/01. Schweizerisches Medizin-Forum pp. 973–976.
 
Venous thromboembolism in centenarians: Findings from the RIETE registry.
Lacruz B., Tiberio G., Núñez M.J., López-Jiménez L., Riera-Mestre A., Tiraferri E., Verhamme P., Mazzolai L., González J., Monreal M. et al., 2016/12. European journal of internal medicine, 36 pp. 62-66. Peer-reviewed.
 
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
Peris M., Jiménez D., Maestre A., Font C., Tafur A.J., Mazzolai L., Xifre B., Skride A., Dentali F., Monreal M. et al., 2016/11. The European respiratory journal, 48 (5) pp. 1360-1368. Peer-reviewed.
Unusual circadian hypertension associated with polydipsia.
Bohlender J.M., Nussberger J., 2016/11. Journal of geriatric cardiology : JGC, 13 (11) pp. 932-934. Peer-reviewed.
 
Antihypertensive treatment and risk of brain ischemia due to carotid stenosis in a survey of hospitalised patients aged 90 years and older
Bohlender Jürgen, Nussberger Jürg, Bohlender Beate, 2016/09., 26th Meeting of the International Society of Hypertension pp. e224 dans ISH 2016 Abstract Book, Journal of Hypertension.
 
Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N., Aujesky D., Beer J.H., Mazzolai L., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W., Escher R. et al., 2016/08/30. Thrombosis and haemostasis, 116 (3) pp. 472-479.
 
DVT Management and Outcome Trends, 2001 to 2014.
Morillo R., Jiménez D., Aibar M.Á., Mastroiacovo D., Wells P.S., Sampériz Á., Saraiva de Sousa M., Muriel A., Yusen R.D., Monreal M. et al., 2016/08. Chest, 150 (2) pp. 374-383. Peer-reviewed.
 
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Douillard C., Houillier P., Nussberger J., Girerd X., 2016/07. Annales d'endocrinologie, 77 (3) pp. 192-201. Peer-reviewed.
 
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L., Baguet J.P., Bardet S., Chaffanjon P., Chamontin B., Douillard C., Durieux P., Girerd X., Gosse P., Hernigou A. et al., 2016/07. Annales d'endocrinologie, 77 (3) pp. 179-186. Peer-reviewed.
Associations Between Cardiovascular Risk Factors, Inflammation, and Progression of Carotid Atherosclerosis Among Smokers.
Zingg S., Collet T.H., Locatelli I., Nanchen D., Depairon M., Bovet P., Cornuz J., Rodondi N., 2016/06. Nicotine & tobacco research, 18 (6) pp. 1533-1538. Peer-reviewed.
 
Maladie de Rendu-Osler. Manifestations cliniques et prise en charge multidisciplinaire [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management]
Frigerio C., Aebischer N., Baud D., Bonafe L., Fellmanne F., Ikonomidis C., Mazzolai L., Michel P., Nichita C., Qanadli S.D. et al., 2016/05/04. Revue medicale suisse, 12 (517) pp. 896-901. Peer-reviewed.
 
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.
Smith V., Beeckman S., Herrick A.L., Decuman S., Deschepper E., De Keyser F., Distler O., Foeldvari I., Ingegnoli F., Müller-Ladner U. et al., 2016/05. Rheumatology, 55 (5) pp. 883-890. Peer-reviewed.
 
Nitric Oxide Deficit Drives Intimal Hyperplasia in Mouse Models of Hypertension.
Allagnat F., Haefliger J.A., Lambelet M., Longchamp A., Bérard X., Mazzolai L., Corpataux J.M., Déglise S., 2016/05. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 51 (5) pp. 733-742. Peer-reviewed.
 
Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions.
Pellegrin M., Szostak J., Bouzourène K., Aubert J.F., Berthelot A., Nussberger J., Laurant P., Mazzolai L., 2016/04/30. Journal of cardiovascular pharmacology and therapeutics, 22 (2) pp. 159-168. Peer-reviewed.
 
Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Aujesky D., Stuck A.K., Beer J.H., Mazzolai L., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2016/04. Seminars in thrombosis and hemostasis, 42 (6) pp. 642-649. Peer-reviewed.
 
Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.
Frasson S., Gussoni G., Di Micco P., Barba R., Bertoletti L., Nuñez M.J., Valero B., Samperiz A.L., Rivas A., Monreal M. et al., 2016/04. Journal of thrombosis and thrombolysis, 41 (3) pp. 404-412.
 
Thrombopénie induite par l'héparine et syndrome de Trousseau
Katchaluba Maria, Glauser Frédéric, Holzer Thomas, Mazzolai Lucia, Alatri Adriano, 2016/03/01. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (09).
 
The year in cardiology 2015: peripheral circulation.
Aboyans V., De Carlo M., Kownator S., Mazzolai L., Meneveau N., Ricco J.B., Vlachopoulos C., Brodmann M., ESC Working Group on Peripheral Circulation, 2016/02/21. European heart journal, 37 (8) pp. 676-685. Peer-reviewed.
 
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.
Jiménez D., de Miguel-Díez J., Guijarro R., Trujillo-Santos J., Otero R., Barba R., Muriel A., Meyer G., Yusen R.D., Monreal M. et al., 2016/01/19. Journal of the American College of Cardiology, 67 (2) pp. 162-170.
 
Accuracy of in-patients ankle-brachial index measurement by medical students.
Monti M., Calanca L., Alatri A., Mazzolai L., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (1) pp. 43-48. Peer-reviewed.
 
Anticoagulation and Renal Insufficiency.
Koulouri A., Calanca L., Mazzolai L., 2016. Therapeutische Umschau. Revue therapeutique, 73 (10) pp. 567-572. Peer-reviewed.
Diabète gestationnel--quelles sont les approches non médicales [Gestational diabetes--what are the non-medical approaches?].
Horsch A., Gross J., Jornayvaz F.R., Lanzi S., Puder J.J., 2016. Revue Médicale Suisse, 12 (521) pp. 1089-1091. Peer-reviewed.
 
Les nouveaux anticoagulants oraux directs. Leurs interactions médicamenteuses et leur utilisation dans des situations particulières
Alatri Adriano, Mazzolai Lucia, 2016/01. info@herz+gefäss.
 
Les nouveaux anticoagulants oraux.
Alatri Adriano, Mazzolai Lucia, 2016. La Gazette Médicale - info@gériatrie 6 pp. 15-17.
 
Maladies Artérielles
Calanca luca, 2016., Elsevier.
 
Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
Engelberger R.P., Ney B., Clair M., Dabiri A., Alatri A., Mazzolai L., Kern P., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (3) pp. 255-258. Peer-reviewed.
 
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A., Schoepfer A., Fournier N., Engelberger R.P., Safroneeva E., Vavricka S., Biedermann L., Calanca L., Mazzolai L., Swiss IBD Cohort Study Group, 2016. Scandinavian Journal of Gastroenterology, 51 (10) pp. 1200-1205. Peer-reviewed.
 
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Portillo J., de la Rocha I.V., Font L., Braester A., Madridano O., Peromingo J.A., Apollonio A., Pagán B., Bascuñana J., Monreal M. et al., 2015/12. Thrombosis research, 136 (6) pp. 1199-1203. Peer-reviewed.
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice.
Giorgi-Pierfranceschi M., Di Micco P., Cattabiani C., Guida A., Pagán B., Morales M.del V., Salgado E., Suriñach J.M., Tolosa C., Monreal M. et al., 2015/11. Medicine, 94 (47) pp. e1915. Peer-reviewed.
9/11 and the Literature of Terror, by Martin Randall
Soltysik Monnet A., 2015/10. Modern Language Review, 110 (4) pp. 1126-1128. Peer-reviewed.
 
Short-term HIIT and Fat max training increase aerobic and metabolic fitness in men with class II and III obesity.
Lanzi S., Codecasa F., Cornacchia M., Maestrini S., Capodaglio P., Brunani A., Fanari P., Salvadori A., Malatesta D., 2015/10. Obesity (silver Spring, Md.), 23 (10) pp. 1987-1994. Peer-reviewed.
 
A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.
Baumann Kreuziger L., Cote L., Verhamme P., Greenberg S., Caprini J., Muñoz F.J., Valle R., Monreal Bosch M., RIETE Investigators, 2015/07. Journal of vascular surgery. Venous and lymphatic disorders, 3 (3) pp. 243-50.e1.
 
Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
Madridano O., del Toro J., Lorenzo A., Martín M., Gómez Cerezo J., Hernández L., Prandoni P., Monreal M., RIETE Investigators, 2015/04. Journal of vascular surgery. Venous and lymphatic disorders, 3 (2) pp. 135-41.e1.
 
Anomalies vasculaires: exemple du syndrome de Klippel-Trenaunay [Vascular anomalies].
Krieger Caroline Ade B, Roessingh Ade B, Depairon M., El Ezzi O., Hohlfeld J., Raffoul W., Qanadli S.D., Mazzolai L., 2015/02. Revue Médicale Suisse, 11 (460) pp. 357-361.
 
A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs.
Trujillo-Santos J., Lozano F., Lorente M.A., Adarraga D., Hirmerova J., Del Toro J., Mazzolai L., Barillari G., Barrón M., Monreal M. et al., 2015. American Journal of Medicine, 128 (1) pp. 90.e9-90.e15. Peer-reviewed.
 
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity.
Rosa-Salazar V., Trujillo-Santos J., Díaz Peromingo J.A., Apollonio A., Sanz O., Malý R., Muñoz-Rodriguez F.J., Serrano J.C., Soler S., Monreal M. et al., 2015. Journal of Thrombosis and Haemostasis : Jth, 13 (7) pp. 1274-1278. Peer-reviewed.
 
Artériopathies non athéromateuses des membres inférieurs [Non atherosclerotic arterial disease of lower limbs].
Calanca L., Alatri A., Depairon M., Engelberger R.P., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 352, 354-352, 356.
 
Biological variation of established and novel biomarkers for atherosclerosis: Results from a prospective, parallel-group cohort study.
Engelberger R.P., Limacher A., Kucher N., Baumann F., Silbernagel G., Benghozi R., Do D.D., Willenberg T., Baumgartner I., 2015. Clinica Chimica Acta, 447 pp. 16-22. Peer-reviewed.
 
CO-10: Are hospitalised patients aged 90 years and over treated well for hypertension? Lessons from a prospective survey.
Bohlender J., Nussberger J., Bohlender B., 2015. Annales de Cardiologie et d'angéiologie, 64 (Suppl 1) pp. S7. Peer-reviewed.
 
Duration of anticoagulation after venous thromboembolism in real world clinical practice.
Ageno W., Samperiz A., Caballero R., Dentali F., Di Micco P., Prandoni P., Becattini C., Uresandi F., Verhamme P., Monreal M. et al., 2015. Thrombosis Research, 135 (4) pp. 666-672. Peer-reviewed.
 
Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Recarti C., Seccia T.M., Caroccia B., Gonzales-Campos A., Ceolotto G., Lenzini L., Petrelli L., Belloni A.S., Rainey W.E., Nussberger J. et al., 2015. Journal of Hypertension, 33 (5) pp. 1014-1022. Peer-reviewed.
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D., Trujillo-Santos J., Debourdeau P., Bura-Riviere A., Rodriguez-Beltrán E.M., Nieto J.A., Peris M.L., Zeltser D., Mazzolai L., Hij A. et al., 2015. Medicine, 94 (32) pp. e1235. Peer-reviewed.
Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo.
van Heeswijk R.B., Pellegrin M., Flögel U., Gonzales C., Aubert J.F., Mazzolai L., Schwitter J., Stuber M., 2015. Radiology, 275 (2) pp. 421-429. Peer-reviewed.
 
Fondaparinux in the initial and long-term treatment of venous thromboembolism.
Pesavento R., Amitrano M., Trujillo-Santos J., Di Micco P., Mangiacapra S., López-Jiménez L., Falgá C., García-Bragado F., Piovella C., Prandoni P. et al., 2015. Thrombosis Research, 135 (2) pp. 311-317. Peer-reviewed.
 
Gender differences in cancer patients with acute venous thromboembolism.
Martín-Martos F., Trujillo-Santos J., Barrón M., Vela J., Javier Marchena P., Braester A., Hij A., Hernández-Blasco L., Verhamme P., Manuel M. et al., 2015. Thrombosis Research, 135 Suppl 1 pp. S12-S15.
 
Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.
Maestre A., Trujillo-Santos J., Riera-Mestre A., Jiménez D., Di Micco P., Bascuñana J., Vela J.R., Peris L., Malfante P.C., Monreal M. et al., 2015. Annals of the American Thoracic Society, 12 (8) pp. 1122-1129. Peer-reviewed.
 
Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: the Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study.
Engelberger R.P., Noll G., Schmidt D., Alatri A., Frei B., Kaiser W.E., Kucher N., 2015. European Journal of Internal Medicine, 26 (7) pp. 508-514. Peer-reviewed.
 
Interplay between connexin40 and nitric oxide signaling during hypertension.
Le Gal L., Alonso F., Mazzolai L., Meda P., Haefliger J.A., 2015. Hypertension, 65 (4) pp. 910-915. Peer-reviewed.
 
La maladie thromboembolique veineuse: cette "inconnue" [Venous thromboembolism: the "unknown"].
Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) p. 335.
 
Le cophénotype sympathique efférent des fibres autonomes angiotensinergiques dans le coeur humain. [Autonomic angiotensinergic fibres in the human heart with an efferent sympathetic cophenotype]
Bohlender J., Nussberger J., Tevaearai H., Imboden H., 2015. Annales de Cardiologie et d'Angéiologie, 64 (3) pp. 175-179. Peer-reviewed.
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Mahé I., Sterpu R., Bertoletti L., López-Jiménez L., Mellado Joan M., Trujillo-Santos J., Ballaz A., Hernández Blasco L.M., Marchena P.J., Monreal M. et al., 2015. Plos One, 10 (6) pp. e0128741. Peer-reviewed.
 
Pathologies vasculaires lymphatiques: apport de la lympho-fluoroscopie [Lymphatic vascular pathologies: contribution of lympho-fluoroscopy].
Tomson D., Lessert C., Luthi I., Mazzolai L., Depairon M., 2015. Revue Médicale Suisse, 11 (460) pp. 362-365.
 
Point-of-Care-Sonografie: Let's keep it simple [Point of care ultrasound].
Gretener S.B., Bieri T., Canova C.R., Engelberger R.P., Küpfer S., Lyrer P., Meuwly J.Y., Staub D., Thalhammer C., 2015. Praxis, 104 (19) pp. 1033-1035.
Prevalence and risk factors for thromboembolic complications in IBD patients
Schoepfer A., Alatri A., Fournier N., Safroneeva E., Calanca L., Mazzolai L., 2015., 10th Congress of ECCO-European Crohns & Colitis Organisation : Inflammatory bowel diseases. 18-21 February 2015, Barcelona, Spain pp. S178-S179 dans Journal of Crohn's & Colitis, Vol. 9 supl.1. Peer-reviewed.
 
Quelle prise en charge pour une suspicion de thrombose veineuse profonde des membres inférieurs [Suspicion of lower limb deep vein thrombosis: update on diagnosis and treatment].
Erdmann A., Alatri A., Engelberger R.P., Depairon M., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 337-341.
Sildenafil as a therapeutic option for digital ischemic ulceration: case report.
Krähenbühl S.M., Depairon M., Faure M., Vietti Violi N., Applegate L.A., Raffoul W., 2015. Journal of Hand Surgery, 40 (5) pp. 890-893. Peer-reviewed.
Staphylococcal biofilm formation on the surface of three different calcium phosphate bone grafts: a qualitative and quantitative in vivo analysis.
Furustrand Tafin U., Betrisey B., Bohner M., Ilchmann T., Trampuz A., Clauss M., 2015. Journal of Materials Science. Materials in Medicine, 26 (3) p. 130. Peer-reviewed.
 
The Atherosclerosis Burden Score (ABS): a Convenient Ultrasound-Based Score of Peripheral Atherosclerosis for Coronary Artery Disease Prediction.
Yerly P., Marquès-Vidal P., Owlya R., Eeckhout E., Kappenberger L., Darioli R., Depairon M., 2015. Journal of Cardiovascular Translational Research, 8 (2) pp. 138-147. Peer-reviewed.
 
The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism.
Spiezia L., Campello E., Trujillo-Santos J., Piovella C., Brenner B., Monreal M., Prandoni P., RIETE Investigators, 2015. Blood Coagulation and Fibrinolysis : An International Journal In Haemostasis and Thrombosis, 26 (6) pp. 709-711. Peer-reviewed.
The year in cardiology 2014: peripheral circulation.
Aboyans V., Brodmann M., De Carlo M., Clement D., Mazzolai L., van Bortel L., van Sambeek M.R., Vlachopoulos C., On Behalf the ESC Working Group of Peripheral Circulation, 2015. European Heart Journal, 36 (10) pp. 591-597. Peer-reviewed.
 
Traitement percutané de la thrombose veineuse profonde aiguë [Catheter-based treatment for acute deep vein thrombosis].
Engelberger R.P., Alatri A., Qanadli S.D., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 348-351. Peer-reviewed.
Ultra-high-resolution 3D imaging of atherosclerosis in mice with synchrotron differential phase contrast: a proof of concept study.
Bonanno G., Coppo S., Modregger P., Pellegrin M., Stuber A., Stampanoni M., Mazzolai L., Stuber M., van Heeswijk R.B., 2015. Scientific Reports, 5 p. 11980. Peer-reviewed.
 
Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis.
Engelberger R.P., Spirk D., Willenberg T., Alatri A., Do D.D., Baumgartner I., Kucher N., 2015. Circulation. Cardiovascular Interventions, 8 (1) pp. e002027. Peer-reviewed.
 
Venous thromboembolism in patients immobilised at home.
López-Reyes R., Nauffal D., Ballester M., Martín-Antorán J.M., de Sousa M.S., Riera-Mestre A., Ruiz-Ruiz J., Fernández-Capitán C., Uresandi F., Monreal M. et al., 2015. European Respiratory Journal, 45 (6) pp. 1728-1731. Peer-reviewed.
Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
Pellegrin M., Aubert J.F., Bouzourène K., Amstutz C., Mazzolai L., 2015. Plos One, 10 (11) pp. e0143536. Peer-reviewed.
 
Traitement de l'ischémie critique chronique des membres inférieurs en 2014 [Treatment of critical lower limb ischemia].
Salomon du Mont L., Déglise S., Dubuis C., Saucy F., Doenz F., Calanca L., Qanadli S., Mazzolai L., Corpataux J M, 2014/10. Revue Médicale Suisse, 10 (447) pp. 1992-1996. Peer-reviewed.
 
Maladies vasculaires rares [Rare vascular diseases].
Calanca L., Depairon M., Tribout B., Aebischer N., Burnier M., Fellmann F., Lazor R., Mazzolai L., 2014/02. Revue Médicale Suisse, 10 (416) pp. 347-50, 352.
 
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
Tzoran I., Brenner B., Sakharov G., Trujillo-Santos J., Lorenzo A., Madridano O., López-Sáez J.B., Monreal M., RIETE investigators, 2014. European Journal of Internal Medicine, 25 (9) pp. 821-825. Peer-reviewed.
 
Coronary sinus atresia with persistent left superior vena cava: unusual clinical presentation and endovascular management.
Qanadli S.D., Rolf T., Glauser F., Delay D., Beigelman-Aubry C., Prêtre R., 2014. Cardiovascular and Interventional Radiology, 37 (3) pp. 825-828.
 
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer.
Maestre A., Trujillo-Santos J., Visoná A., Lobo J.L., Grau E., Malý R., Duce R., Monreal M., RIETE Investigators, 2014. Thrombosis Research, 133 (3) pp. 384-389. Peer-reviewed.
Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T-cell polarization during early and late stages.
Pellegrin M., Bouzourène K., Poitry-Yamate C., Mlynarik V., Feihl F., Aubert J.F., Gruetter R., Mazzolai L., 2014. Physiological Reports, 2 (2) pp. e00234. Peer-reviewed.
 
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
Lozano F., Trujillo-Santos J., Barrón M., Gallego P., Babalis D., Santos M., Falgá C., Monreal M., RIETE Investigators, 2014. Journal of Vascular Surgery, 59 (5) pp. 1362-7.e1. Peer-reviewed.
 
Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism.
Trujillo-Santos J., Gussoni G., Gadelha T., Sänchez Muñoz-Torrero J.F., Barron M., Lopez L., Ruiz-Ruiz J., Fernandez-Capitan C., Lorente M., Monreal M. et al., 2014. Thrombosis Research, 133 (Suppl 2) pp. S29-S34. Peer-reviewed.
 
Interaction between widening of diameter of abdominal aorta and cardiovascular risk factors and atherosclerosis burden.
Glauser F., Mazzolai L., Darioli R., Depairon M., 2014. Internal and Emergency Medicine, 9 (4) pp. 411-417.
 
No major impact of skin aging on the response of skin blood flow to a submaximal local thermal stimulus.
Vionnet J., Calero-Romero I., Heim A., Rotaru C., Engelberger R.P., Dischl B., Noël B., Liaudet L., Waeber B., Feihl F., 2014. Microcirculation, 21 (8) pp. 730-737. Peer-reviewed.
 
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
Cote L.P., Greenberg S., Caprini J.A., Stone J., Arcelus J.I., López-Jiménez L., Rosa V., Schellong S., Monreal M., RIETE Investigators, 2014. Clinical and Applied Thrombosis/hemostasis, 20 (8) pp. 772-778. Peer-reviewed.
 
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
Blanco-Molina A., Enea I., Gadelha T., Tufano A., Bura-Riviere A., Di Micco P., Bounameaux H., González J., Villalta J., Monreal M. et al., 2014. Medicine, 93 (17) pp. 309-317. Peer-reviewed.
 
Thrombosis of palmar and interdigital arteries in the hypereosinophilic syndrome.
Gallardo C., Mancinetti M., Périard D., Hayoz D., 2014. Vasa. Zeitschrift Für Gefässkrankheiten, 43 (3) pp. 222-224. Peer-reviewed.
Use of plasma Renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
Baumstark M.E., Nussberger J., Boretti F.S., Baumstark M.W., Riond B., Reusch C.E., Sieber-Ruckstuhl N.S., 2014. Journal of Veterinary Internal Medicine, 28 (5) pp. 1471-1478. Peer-reviewed.
 
Variabilité des concentrations plasmatiques de l'angiotensinogène et risque d'hypertension artérielle chez le rat transgénique [Variability of plasma angiotensinogen levels and risk of hypertension in a transgenic rat model].
Gudo B., Nussberger J., Bohlender J., 2014. Annales de Cardiologie et d'angéiologie, 63 (3) pp. 124-127. Peer-reviewed.
 
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.
den Exter P.L., Gómez V., Jiménez D., Trujillo-Santos J., Muriel A., Huisman M.V., Monreal M., Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators, 2013. Chest, 143 (1) pp. 138-145.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University